Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors

被引：33

作者：

Fucini, Raymond V. ^{[1
]}

Hanan, Emily J. ^{[2
]}

Romanowski, Michael J. ^{[3
]}

Elling, Robert A. ^{[3
]}

Lew, Willard ^{[2
]}

Barr, Kenneth J. ^{[2
]}

Zhu, Jiang ^{[2
]}

Yoburn, Joshua C. ^{[2
]}

Liu, Yang ^{[2
]}

Fahr, Bruce T. ^{[2
]}

Fan, Junfa ^{[2
]}

Lu, Yafan ^{[2
]}

Pham, Phuongly ^{[2
]}

Choong, Ingrid C. ^{[2
]}

VanderPorten, Erica C. ^{[1
]}

Bui, Minna ^{[2
]}

Purkey, Hans E. ^{[2
]}

Evanchik, Marc J. ^{[1
]}

Yang, Wenjin ^{[2
]}

机构：

[1] Sunesis Pharmaceut Inc, Dept Biol, San Francisco, CA 94080 USA

[2] Sunesis Pharmaceut Inc, Dept Chem, San Francisco, CA 94080 USA

[3] Sunesis Pharmaceut Inc, Dept Biol Struct, San Francisco, CA 94080 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 20期

关键词：

2-amino-pyrazolopyridine; Polo-like kinase (Plk); SAR; kinase inhibitor;

D O I：

10.1016/j.bmcl.2008.08.095

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 2-amino-pyrazolopyridines was designed and synthesized as Polo-like kinase (Plk) inhibitors based on a low micromolar hit. The SAR was developed to provide compounds exhibiting low nanomolar inhibitory activity of Plk1; the phenotype of treated cells is consistent with Plk1 inhibition. A co-crystal structure of one of these compounds with zPlk1 confirms an ATP-competitive binding mode. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：5648 / 5652

页数：5

共 50 条

[1] Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors
Hanan, Emily J.
Fucini, Raymond V.
Romanowski, Michael J.
Elling, Robert A.
Lew, Willard
Purkey, Hans E.
VanderPorten, Erica C.
Yang, Wenjin
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (19) : 5186 - 5189
[2] Developing polo-like kinase 1 inhibitors
Huang, Xufeng
Xie, Zhouling
Liao, Chenzhong
FUTURE MEDICINAL CHEMISTRY, 2020, 12 (10) : 869 - 871
[3] Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors
Lin, Tong-yuan
Min, Hong-ping
Jiang, Cheng
Niu, Miao-miao
Yan, Fang
Xu, Li-li
Di, Bin
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (12) : 3429 - 3437
[4] Regioselective synthesis of benzimidazole thiophene inhibitors of polo-like kinase 1
Hornberger, Keith R.
Badiang, Jennifer G.
Salovich, James M.
Kuntz, Kevin W.
Emmitte, Kyle A.
Cheung, Mui
TETRAHEDRON LETTERS, 2008, 49 (44) : 6348 - 6351
[5] Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1
Berg, Angela
Berg, Thorsten
CHEMBIOCHEM, 2016, 17 (08) : 650 - 656
[6] Design, Synthesis and Structure of Peptidomimetic Inhibitors of Polo-like Kinase 1: A Target for Cancer Chemotherapy
Murugan, Ravichandran N.
Park, Jae Hoon
Lee, Kyung S.
Bang, Jeong Kyu
BIOPOLYMERS, 2011, 96 (04) : 484 - 484
[7] SYNTHESIS OF SMALL PEPTIDE INHIBITORS TO THE POLO-BOX DOMAIN OF POLO-LIKE KINASE 1
Ahn, M.
Park, J. -E.
Lee, K. S.
Shin, S. Y.
Bang, J. K.
JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S155 - S155
[8] Application of a Fluorescence Recovery-Based Polo-Like Kinase 1 Binding Assay to Polo-Like Kinase 2 and Polo-Like Kinase 3
Tsuji, Kohei
Tamamura, Hirokazu
Burke Jr, Terrence R.
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (07) : 1282 - 1287
[9] Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
Jani, Krupa S.
Dalafave, D. S.
BIOINFORMATICS AND BIOLOGY INSIGHTS, 2012, 6 : 23 - 31
[10] Synthesis of Peptide Mimetic Inhibitors Targeting Polo-Box Domain of Polo-like Kinase 1
Bang, J. K.
Song, Y. S.
Park, J. E.
Murugan, R. N.
Ahn, M.
Lee, K. S.
JOURNAL OF PEPTIDE SCIENCE, 2012, 18 : S192 - S193

← 1 2 3 4 5 →